GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.670
-0.170 (-9.24%)
Apr 24, 2025, 4:00 PM EDT - Market closed

GRI Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
172---
Market Cap Growth
325.43%325.43%----
Enterprise Value
-43-2---
Last Close Price
1.6714.08595.52---
PB Ratio
0.221.846.72---
P/TBV Ratio
0.221.846.72---
Debt / Equity Ratio
0.030.030.05-0.41-0.74-0.62
Quick Ratio
3.073.070.670.010.020.07
Current Ratio
3.433.431.090.160.020.07
Return on Equity (ROE)
-382.52%-382.52%----
Return on Assets (ROA)
-118.39%-118.39%-416.93%-465.68%-226.54%-
Return on Capital (ROIC)
-232.68%-232.68%----
Earnings Yield
-1153.25%-110.90%-749.46%---
FCF Yield
-981.48%-116.36%-517.27%---
Buyback Yield / Dilution
-----2.26%-
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q